The Naturalistic Cannabis Administration Protocol (NCAP): A Proof-of-Concept Study

被引:1
|
作者
St Pierre, Michelle [1 ]
Daniels, Sarah [1 ]
Sanchez, Tatiana A. [1 ]
Holtzman, Susan [1 ]
Russo, Ethan B. [2 ]
Walsh, Zach [1 ]
机构
[1] Univ British Columbia, Dept Psychol, ASC 207,3187 Univ Way, Kelowna, BC V1V 1V7, Canada
[2] CReDO Sci, Vashon, WA USA
基金
加拿大健康研究院;
关键词
Methodology; experimental design; cannabis research; acute cannabis intoxication; PERFORMANCE; TOLERANCE; MARIJUANA; ALCOHOL; HEAVY;
D O I
10.1080/02791072.2022.2125466
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Lab-based studies examining the effects of cannabis administration on human behavior compromise ecological validity due to the influence of set and setting. Contextual factors of clinical settings have long been recognized as producing measurable changes in physiology, emotionality, and cognition. Among people who use drugs, these settings may be associated with higher levels of perceived stigma and stereotype threat which may meaningfully confound the effects of cannabis on outcomes of interest. Recent liberalization of cannabis regulation may allow novel and more ecologically valid approaches to assessing the acute effects of cannabis. The Naturalistic Cannabis Administration Protocol (NCAP) is a novel paradigm for the study of acute cannabis effects in an ecologically valid manner. Two independent studies demonstrated the safety and feasibility of the NCAP. Participants (N= 79; M-age = 25.44, SD = 5.67) self-administered the cannabis of their choice in their home and then (Study 1; n= 47) engaged in a leisure activity or (Study 2; n= 32) underwent cognitive assessment remotely via videoconference following cannabis administration. The NCAP was well tolerated across samples with no reported adverse events. These findings provide a rationale for the adoption of the NCAP to reduce research barriers and develop our research capabilities to fit the landscape of cannabis use today.
引用
收藏
页码:389 / 401
页数:13
相关论文
共 50 条
  • [41] EvolvRehab-MoveWell telerehabilitation for stroke survivors: study protocol for a feasibility with embedded initial proof-of-concept study
    Perks, Jemma
    Mcbride, Philip
    Mansoubi, Maedeh
    Clatworthy, Philip
    Hulme, Claire
    Taylor, Gordon
    Warner, Martin
    Dawes, Helen
    [J]. BMJ OPEN, 2024, 14 (05):
  • [42] Virtual reality exposure therapy as treatment for pain catastrophizing in fibromyalgia patients: proof-of-concept study (Study Protocol)
    Morris, Linzette D.
    Grimmer-Somers, Karen A.
    Spottiswoode, Bruce
    Louw, Quinette A.
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2011, 12
  • [43] Virtual reality exposure therapy as treatment for pain catastrophizing in fibromyalgia patients: proof-of-concept study (Study Protocol)
    Linzette D Morris
    Karen A Grimmer-Somers
    Bruce Spottiswoode
    Quinette A Louw
    [J]. BMC Musculoskeletal Disorders, 12
  • [44] RNAi: From Concept to Human Proof-of-Concept
    Vaishnaw, Akshay
    Nochur, Sara
    Ftizgerlad, Kevin
    Simon, Amy
    Gollob, Jared
    [J]. NUCLEIC ACID THERAPEUTICS, 2012, 22 (06) : A12 - A12
  • [45] Inhibitory Control Training for Anxiety and Math Achievement in Primary School Children: Protocol for a Proof-of-Concept Study
    Edwards, Elizabeth
    Chu, Khanh Linh
    Carroll, Annemaree
    [J]. JMIR RESEARCH PROTOCOLS, 2024, 13
  • [46] A proof-of-concept investigation into ketamine as a pharmacological treatment for alcohol dependence: study protocol for a randomised controlled trial
    Amy McAndrew
    Will Lawn
    Tobias Stevens
    Lilla Porffy
    Brigitta Brandner
    Celia J. A. Morgan
    [J]. Trials, 18
  • [47] Evaluating a Novel Infant Heart Rate Detector for Neonatal Resuscitation Efforts: Protocol for a Proof-of-Concept Study
    Abdou, Abdelrahman
    Krishnan, Sridhar
    Mistry, Niraj
    [J]. JMIR RESEARCH PROTOCOLS, 2023, 12
  • [48] A proof-of-concept investigation into ketamine as a pharmacological treatment for alcohol dependence: study protocol for a randomised controlled trial
    McAndrew, Amy
    Lawn, Will
    Stevens, Tobias
    Porffy, Lilla
    Brandner, Brigitta
    Morgan, Celia J. A.
    [J]. TRIALS, 2017, 18
  • [49] Is epinephrine administration by sublingual tablet feasible for the first-aid treatment of anaphylaxis? A proof-of-concept study
    Gu, XC
    Simons, KJ
    Simons, FER
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 2002, 23 (05) : 213 - 216
  • [50] Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine: A Proof-of-Concept Study
    Roozen, Geert V. T.
    Prins, Margaretha L. M.
    van Binnendijk, Rob
    den Hartog, Gerco
    Kuiper, Vincent P.
    Prins, Corine
    Janse, Jacqueline J.
    Kruithof, Annelieke C.
    Feltkamp, Mariet C. W.
    Kuijer, Marjan
    Rosendaal, Frits R.
    Roestenberg, Meta
    Visser, Leo G.
    Roukens, Anna H. E.
    [J]. ANNALS OF INTERNAL MEDICINE, 2022, 175 (12) : 1771 - +